AMRX

AMNEAL PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.17

EPS Forecast

$714.6

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$0.17

Revenue Forecast:

$714.6

EPS Surprise Forecast:

$0.016

Revenue Surprise Forecast:

$5

Post-release price volatility - High

Post-release Overnight Move:

±7.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

65%

Probability of beating revenue consensus:

63%

Probability of beating both EPS & revs consensus:

47%

Probability of missing both EPS & revs consensus:

19%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

0.87

Earnings volatility

EPS standard deviation:

$0.11

Revenue standard deviation:

$36

As % of share price:

0.92% HIGH

As % of market cap:

0.93% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.31

Revenue 95th %ile:

$762

EPS 75th %ile:

$0.21

Revenue 75th %ile:

$727

EPS 25th %ile:

$0.13

Revenue 25th %ile:

$704

EPS 5th %ile:

$0.04

Revenue 5th %ile:

$675

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

40% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

39% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$11

Bid-ask per Share:

$0.015